Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India
The Journal of Infection in Developing Countries · 2023
DOI: 10.3855/jidc.17237 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2023. Verfasst von Srikanta Kanungo und 21 weiteren Autor:innen. Beteiligte Einrichtung: ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India. Hauptthemen laut MEDLINE: COVID-19. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Personnel involved in essential services or residing in high-risk areas during the COVID-19 pandemic are at increased risk of getting infected. We evaluated the proportion of personnel infected in several high-risk groups in Odisha using seroprevalence studies. Methodology: During July to November, 2020, individuals from multiple high-risk groups in 6 urban cities (Bhubaneswar, Berhampur, Cuttack, Malkangiri, Paralakhemundi, and Rourkela) in Odisha, India, were recruited to the study after obtaining written informed consent. Blood samples collected from the study participants were tested for IgG antibodies against COVID-19 in Roche Cobas e441 (Roche Diagnostics, Rotkreuz, Switzerland). Information on socio-demographic variables, association with a confirmed or suspected case, and other details were collected using an electronic data capture tool and analysed with a statistical software.
Results
The overall COVID-19 seroprevalence was 34.9% (95%CI 33.6-36.2) among the 5434 individuals. The seroprevalence varied from 21.8% (95% CI, 19.6-24.1) in Rourkela to 54.9% (95% CI, 51.5-58.2) in Bhubaneswar. Seropositivity was maximum among prisoners (47.7%), followed by municipality/ sanitation staff (43.5%), and other office going staff (40.8%). Multivariate logistic regression indicated that participants aged 18-29 years, 30-44 years, residents of slums and vending zone, municipality staff, prisoners, residents of urban cities Malkangiri, Cuttack, Paralakhemundi, Bhubaneswar and those with previous history of COVID-19 were independent co-relates of seropositivity.
Conclusions
The risk of COVID-19 varied among the high-risk groups of Odisha. Periodic seroprevalence studies in future are essential to protect the high-risk personnel involved in frontline activities during the pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ICMR - Regional Medical Research Centre, Bhubaneswar, Odisha, India.
- Employee's State Insurance Corporation (ESIC) Hospital, Rourkela, Odisha, India.
- Department of Community Medicine, Maharaja Krushna Chandra Gajapati (MKCG) Medical College and Hospital, Berhampur, Odisha, India.
Zitieren
APA
Kanungo, S., Giri, S., Bhattacharya, D., Kshatri, J. S., Palo, S. K., Parai, D., Turuk, J., Praharaj, I., Mansingh, A., Dash, G. C., Choudhary, H. R., Pattnaik, M., Barik, S. R., Mohanta, A. R., Swain, A., Mohapatra, I., Sahoo, R. K., Mishra, R. P., Patro, S. K., …, & ICMR-RMRC [OdiSHA-COVID-19] Serosurvey Team (2023). Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.17237
Vancouver
Kanungo S, Giri S, Bhattacharya D, Kshatri JS, Palo SK, Parai D, et al. Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India. The Journal of Infection in Developing Countries. 2023. doi:10.3855/jidc.17237
BibTeX
@article{Kanungo2023,
author = {Kanungo, Srikanta and Giri, Sidhartha and Bhattacharya, Debdutta and Kshatri, Jaya Singh and Palo, Subrata Kumar and Parai, Debaprasad and Turuk, Jyotirmayee and Praharaj, Ira and Mansingh, Asit and Dash, Girish Chandra and Choudhary, Hari Ram and Pattnaik, Matrujyoti and Barik, Shakti Ranjan and Mohanta, Amiya Ranjan and Swain, Aparajita and Mohapatra, Ira and Sahoo, Rakesh Kumar and Mishra, Rudra Prasanna and Patro, Sithun Kumar and Satapathy, Durga Madhab and Pati, Sanghamitra and ICMR-RMRC [OdiSHA-COVID-19] Serosurvey Team, ICMR-RMRC [OdiSHA-COVID-19] Serosurvey Team},
title = {Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India},
journal = {The Journal of Infection in Developing Countries},
year = {2023},
doi = {10.3855/jidc.17237}
}
EUVIMED